Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Tal, Reshef ^a   Seifer, David B ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MUELLERIAN INHIBITING FACTOR;

AGING; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; HEREDITY; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY; INFERTILITY THERAPY; MINORITY GROUP; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OVARIAN RESERVE; PRIORITY JOURNAL; PUBERTY; RACE DIFFERENCE; REPRODUCTION; REVIEW; SMOKING; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

EID: 84890063772     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/818912     Document Type: Review

References (82)

1. Wu T., Mendola P., Buck G. M., Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 2002 110 4 752 757 2-s2.0-0036791149 10.1542/peds.110.4.752
2. Herman-Giddens M. E., Slora E. J., Wasserman R. C., Bourdony C. J., Bhapkar M. V., Koch G. G., Hasemeier C. M., Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 1997 99 4 505 512 2-s2.0-0031004856
3. Abma J. C., Chandra A., Mosher W. D., Peterson L. S., Piccinino L. J., Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital and Health Statistics 1997 23 19 1 114 2-s2.0-0031136443
4. Stephen E. H., Chandra A., Declining estimates of infertility in the United States: 1982-2002. Fertility and Sterility 2006 86 3 516 523 2-s2.0-33748125004 10.1016/j.fertnstert.2006.02.129 (Pubitemid 44307044)
5. Sharara F. I., McClamrock H. D., Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program. Fertility and Sterility 2000 73 6 1170 1173 2-s2.0-0034077670 10.1016/S0015-0282(00)00524-0 (Pubitemid 30336763)
6. Fujimoto V. Y., Luke B., Brown M. B., Jain T., Armstrong A., Grainger D. A., Hornstein M. D., Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertility and Sterility 2010 93 2 382 390 2-s2.0-74449092898 10.1016/j.fertnstert.2008.10.061
7. Seifer D. B., Zackula R., Grainger D. A., Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. Fertility and Sterility 2010 93 2 626 635 2-s2.0-74449085138 10.1016/j.fertnstert.2009.02.084
8. Seifer D. B., Frazier L. M., Grainger D. A., Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertility and Sterility 2008 90 5 1701 1710 2-s2.0-55249089975 10.1016/j.fertnstert.2007.08.024
9. Baker V. L., Luke B., Brown M. B., Alvero R., Frattarelli J. L., Usadi R., Grainger D. A., Armstrong A. Y., Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertility and Sterility 2010 94 4 1410 1416 2-s2.0-77956183245 10.1016/j.fertnstert.2009.07.986
10. Jain T., Hornstein M. D., Disparities in access to infertility services in a state with mandated insurance coverage. Fertility and Sterility 2005 84 1 221 223 2-s2.0-22244459580 10.1016/j.fertnstert.2005.01.118 (Pubitemid 40991485)
11. Missmer S. A., Seifer D. B., Jain T., Cultural factors contributing to health care disparities among patients with infertility in Midwestern United States. Fertility and Sterility 2011 95 6 1943 1949 2-s2.0-79955002346 10.1016/j.fertnstert.2011.02.039
12. Stanford J. L., Hartge P., Brinton L. A., Hoover R. N., Brookmeyer R., Factors influencing the age at natural menopause. Journal of Chronic Diseases 1987 40 11 995 1002 2-s2.0-0023641065 (Pubitemid 17153888)
13. Bromberger J. T., Matthews K. A., Kuller L. H., Wing R. R., Meilahn E. N., Plantinga P., Prospective study of the determinants of age at menopause. American Journal of Epidemiology 1997 145 2 124 133 2-s2.0-0031013059 (Pubitemid 27045318)
14. MacMahon B., Worcester J., Age at menopause. United States 1960-1962. Vital and Health Statistics 1966 11 19 1 20 2-s2.0-0013955174
15. Randolph J. F. Jr., Sowers M., Gold E. B., Mohr B. A., Luborsky J., Santoro N., McConnell D. S., Finkelstein J. S., Korenman S. G., Matthews K. A., Sternfeld B., Lasley B. L., Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. Journal of Clinical Endocrinology and Metabolism 2003 88 4 1516 1522 2-s2.0-0038022615 10.1210/jc.2002-020777 (Pubitemid 36623363)
16. Gold E. B., Sternfeld B., Kelsey J. L., Brown C., Mouton C., Reame N., Salamone L., Stellato R., Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. American Journal of Epidemiology 2000 152 5 463 473 2-s2.0-0034282411 10.1093/aje/152.5.463
17. Freeman E. W., Sammel M. D., Gracia C. R., Kapoor S., Lin H., Liu L., Nelson D. B., Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertility and Sterility 2005 83 2 383 392 2-s2.0-13544262557 10.1016/j.fertnstert.2004.06.066 (Pubitemid 40221793)
18. Luborsky J. L., Meyer P., Sowers M. F., Gold E. B., Santoro N., Premature menopause in a multi-ethnic population study of the menopause transition. Human Reproduction 2003 18 1 199 206 2-s2.0-0037248189 10.1093/humrep/deg005 (Pubitemid 36138877)
19. Seifer D. B., MacLaughlin D. T., Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertility and Sterility 2007 88 3 539 546 2-s2.0-34548410798 10.1016/j.fertnstert.2007.02.014 (Pubitemid 47368260)
20. Seifer D. B., MacLaughlin D. T., Christian B. P., Feng B., Shelden R. M., Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertility and Sterility 2002 77 3 468 471 2-s2.0-0036177644 10.1016/S0015-0282(01)03201-0 (Pubitemid 34177199)
21. van Rooij I. A. J., den Tonkelaar I., Broekmans F. J. M., Looman C. W. N., Scheffer G. J., de Jong F. H., Themmen A. P. N., Te Velde E. R., Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004 11 6 601 606 2-s2.0-14844362723 10.1097/01.GME.0000123642.76105.6E (Pubitemid 40353222)
22. de Vet A., Laven J. S. E., de Jong F. H., Themmen A. P. N., Fauser B. C. J. M., Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertility and Sterility 2002 77 2 357 362 2-s2.0-0036155640 10.1016/S0015-0282(01)02993-4 (Pubitemid 34083560)
23. la Marca A., Stabile G., Carducci Artenisio A., Volpe A., Serum anti-Mullerian hormone throughout the human menstrual cycle. Human Reproduction 2006 21 12 3103 3107 2-s2.0-33751368487 10.1093/humrep/del291 (Pubitemid 44811610)
24. la Marca A., Giulini S., Orvieto R., de Leo V., Volpe A., Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Human Reproduction 2005 20 6 1569 1572 2-s2.0-20744431924 10.1093/humrep/deh819 (Pubitemid 40852249)
25. Somunkiran A., Yavuz T., Yucel O., Ozdemir I., Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. European Journal of Obstetrics Gynecology and Reproductive Biology 2007 134 2 196 201 2-s2.0-34548820981 10.1016/j.ejogrb.2007.01.012 (Pubitemid 47451601)
26. Seifer D. B., Golub E. T., Lambert-Messerlian G., Benning L., Anastos K., Watts D. H., Cohen M. H., Karim R., Young M. A., Minkoff H., Greenblatt R. M., Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. Fertility and Sterility 2009 92 5 1674 1678 2-s2.0-70350749638 10.1016/j.fertnstert.2008.08.110
27. Gleicher N., Kim A., Weghofer A., Barad D. H., Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reproductive Biology and Endocrinology 2012 10, article 77 10.1186/1477-7827-10-77
28. Rustamov O., Smith A., Roberts S. A., Yates A. P., Fitzgerald C., Krishnan M., Nardo L. G., Pemberton P. W., Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Human Reproduction 2012 27 10 3085 3091 10.1093/humrep/des260
29. Rustamov O., Pemberton P. W., Roberts S. A., Smith A., Yates A. P., Patchava S. D., Nardo L. G., The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability. Fertility and Sterility 2011 95 3 1185 1187 2-s2.0-79951953226 10.1016/j.fertnstert.2010. 10.001
30. Block E., Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anatomica 1952 14 1-2 108 123 2-s2.0-76949115503
31. Block E., A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anatomica 1953 17 3 201 206 2-s2.0-0000502506
32. McGee E. A., Hsueh A. J. W., Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews 2000 21 2 200 214 2-s2.0-0034453103 10.1210/er.21.2.200 (Pubitemid 32275595)
33. Snieder H., Macgregor A. J., Spector T. D., Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. Journal of Clinical Endocrinology and Metabolism 1998 83 6 1875 1880 2-s2.0-0031760136 10.1210/jc.83.6.1875 (Pubitemid 28496309)
34. de Bruin J. P., Bovenhuis H., Van Noord P. A. H., Pearson P. L., van Arendonk J. A. M., Te Velde E. R., Kuurman W. W., Dorland M., The role of genetic factors in age at natural menopause. Human Reproduction 2001 16 9 2014 2018 2-s2.0-0034815279 (Pubitemid 32916239)
35. Meyer J. M., Eaves L. J., Heath A. C., Martin N. G., Estimating genetic influences on the age-at-menarche: a survival analysis approach. American Journal of Medical Genetics 1991 39 2 148 154 2-s2.0-0025729099
36. Rosen M. P., Johnstone E. B., Gillham S. J., Modan A. E., Lipshutz A. K. M., Reijo-Pera R., Cedars M. I., Is antral follicle count a genetic trait? Menopause 2010 17 1 109 113 2-s2.0-74549173501 10.1097/gme.0b013e3181b48a88
37. Schuh-Huerta S. M., Johnson N. A., Rosen M. P., Sternfeld B., Cedars M. I., Reijo Pera R. A., Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women. Human Reproduction 2012 27 2 594 608 2-s2.0-84855871252 10.1093/humrep/der391
38. Ben-Shlomo I., Vitt U. A., Hsueh A. J. W., Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database. Endocrinology 2002 143 6 2041 2044 2-s2.0-0036092967 10.1210/en.143.6.2041 (Pubitemid 34521550)
39. Schuh-Huerta S. M., Johnson N. A., Rosen M. P., Sternfeld B., Cedars M. I., Reijo Pera R. A., Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities. Human Genetics 2012 131 11 1709 1724 10.1007/s00439-012-1184-0
40. Gleicher N., Weghofer A., Oktay K., Barad D., Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reproductive Biomedicine Online 2009 19 3 385 390 2-s2.0-77649278097
41. Gleicher N., Weghofer A., Barad D. H., Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reproductive BioMedicine Online 2010 20 6 768 775 2-s2.0-77954309591 10.1016/j.rbmo.2010.02.020
42. Gleicher N., Weghofer A., Kim A., Barad D. H., The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012 7 3 2-s2.0-84858602064 10.1371/journal.pone.0033638 e33638
43. Gleicher N., Weghofer A., Barad D. H., Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reproductive BioMedicine Online 2010 20 4 485 491 2-s2.0-77951652465 10.1016/j.rbmo.2009.12.017
44. Narod S. A., BRCA mutations in the management of breast cancer: the state of the art. Nature Reviews Clinical Oncology 2010 7 12 702 707 2-s2.0-78649663174 10.1038/nrclinonc.2010.166
45. Kauff N. D., Satagopan J. M., Robson M. E., Scheuer L., Hensley M., Hudis C. A., Ellis N. A., Boyd J., Borgen P. I., Barakat R. R., Norton L., Castiel M., Nafa K., Offit K., Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. The New England Journal of Medicine 2002 346 21 1609 1615 2-s2.0-0037162115 10.1056/NEJMoa020119 (Pubitemid 34755668)
46. Oktay K., Kim J. Y., Barad D., Babayev S. N., Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. Journal of Clinical Oncology 2010 28 2 240 244 2-s2.0-74949092641 10.1200/JCO.2009.24.2057
47. Rzepka-Górska I., Tarnowski B., Chudecka-Głaz A., Górski B., Zielińska D., Tołoczko-Grabarek A., Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Research and Treatment 2006 100 1 59 63 2-s2.0-36049032371 10.1007/s10549-006-9220-1
48. Titus S., Li F., Stobezki R., Akula K., Unsal E., Jeong K., Dickler M., Robson M., Moy F., Goswami S., Oktay K., Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Science Translational Medicine 2013 5 172ra121
49. John E. M., Miron A., Gong G., Phipps A. I., Felberg A., Li F. P., West D. W., Whittemore A. S., Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. Journal of the American Medical Association 2007 298 24 2869 2876 2-s2.0-37549036689 10.1001/jama.298.24.2869
50. Newman B., Mu H., Butler L. M., Millikan R. C., Moorman P. G., King M.-C., Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. Journal of the American Medical Association 1998 279 12 915 921 2-s2.0-0032565070 10.1001/jama.279.12.915 (Pubitemid 28136080)
51. Malone K. E., Daling J. R., Doody D. R., Hsu L., Bernstein L., Coates R. J., Marchbanks P. A., Simon M. S., McDonald J. A., Norman S. A., Strom B. L., Burkman R. T., Ursin G., Deapen D., Weiss L. K., Folger S., Madeoy J. J., Friedrichsen D. M., Suter N. M., Humphrey M. C., Spirtas R., Ostrander E. A., Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Research 2006 66 16 8297 8308 2-s2.0-33748092354 10.1158/0008-5472.CAN- 06-0503 (Pubitemid 44299201)
52. Flegal K. M., Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 2010 303 3 235 241 2-s2.0-74549140993 10.1001/jama.2009.2014
53. Kupka M. S., Gnoth C., Buehler K., Dahncke W., Kruessel J.-S., Impact of female and male obesity on IVF/ICSI: Results of 700,000 ART-cycles in Germany. Gynecological Endocrinology 2011 27 3 144 149 2-s2.0-79751515065 10.3109/09513590.2010.487617
54. Zhang D., Zhu Y., Gao H., Zhou B., Zhang R., Wang T., Ding G., Qu F., Huang H., Lu X., Overweight and obesity negatively affect the outcomes of ovarian stimulation and invitro fertilisation: a cohort study of 2628 Chinese women. Gynecological Endocrinology 2010 26 5 325 332 2-s2.0-77951129468 10.3109/09513591003632100
55. Maheshwari A., Stofberg L., Bhattacharya S., Effect of overweight and obesity on assisted reproductive technology-a systematic review. Human Reproduction Update 2007 13 5 433 444 2-s2.0-34548141863 10.1093/humupd/dmm017 (Pubitemid 47299850)
56. Dechaud H., Anahory T., Reyftmann L., Loup V., Hamamah S., Hedon B., Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. European Journal of Obstetrics Gynecology and Reproductive Biology 2006 127 1 88 93 2-s2.0-33745398880 10.1016/j.ejogrb.2005.12.009 (Pubitemid 43947436)
57. Freeman E. W., Gracia C. R., Sammel M. D., Lin H., Lim L. C.-L., Strauss J. F. III, Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertility and Sterility 2007 87 1 101 106 2-s2.0-33845793406 10.1016/j.fertnstert.2006.05.074 (Pubitemid 46013875)
58. Steiner A. Z., Stanczyk F. Z., Patel S., Edelman A., Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 2010 81 3 245 248 2-s2.0-76049129852 10.1016/j.contraception.2009.10.004
59. Buyuk E., Seifer D. B., Illions E., Grazi R. V., Lieman H., Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertility and Sterility 2011 95 7 2364 2368 2-s2.0-79956369110 10.1016/j.fertnstert.2011.03.081
60. Wu L. L.-Y., Dunning K. R., Yang X., Russell D. L., Lane M., Norman R. J., Robker R. L., High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates. Endocrinology 2010 151 11 5438 5445 2-s2.0-77957727931 10.1210/en.2010-0551
61. Su H. I., Sammel M. D., Freeman E. W., Lin H., Deblasis T., Gracia C. R., Body size affects measures of ovarian reserve in late reproductive age women. Menopause 2008 15 5 857 861 2-s2.0-58249086299 10.1097/gme.0b013e318165981e
62. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
63. Ledoux S., Campos D. B., Lopes F. L., Dobias-Goff M., Palin M.-F., Murphy B. D., Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 2006 147 11 5178 5186 2-s2.0-33751200645 10.1210/en.2006-0679 (Pubitemid 44790572)
64. Merhi Z., Buyuk E., Berger D. S., Zapantis A., Israel D. D., Chua S., Jindal S., Leptin suppresses anti-Mullerian hormone gene expression through the JAK2/STAT3 pathway in luteinized granulosa cells of women undergoing IVF. Human Reproduction 2013 28 6 1661 1669 10.1093/humrep/det072
65. Merhi Z. O., Seifer D. B., Weedon J., Adeyemi O., Holman S., Anastos K., Golub E. T., Young M., Karim R., Greenblatt R., Minkoff H., Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertility and Sterility 2012 98 228 234 2-s2.0-84859400489 10.1016/j.fertnstert.2012.03.029
66. Dennis N. A., Houghton L. A., Jones G. T., van Rij A. M., Morgan K., McLennan I. S., The level of serum anti-mullerian hormone correlates with vitamin d status in men and women but not in boys. The Journal of Clinical Endocrinology & Metabolism 2012 97 2450 2455 10.1210/jc.2012-1213
67. Coney P., Demers L. M., Dodson W. C., Kunselman A. R., Ladson G., Legro R. S., Determination of vitamin D in relation to body mass index and race in a defined population of black and white women. International Journal of Gynecology & Obstetrics 2012 119 1 21 25 10.1016/j.ijgo.2012.05.024
68. Malloy P. J., Peng L., Wang J., Feldman D., Interaction of the vitamin D receptor with a vitamin D response element in the müllerian-inhibiting substance (MIS) promoter: Regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 2009 150 4 1580 1587 2-s2.0-63849254941 10.1210/en.2008-1555
69. Adeyemi O. M., Agniel D., French A. L., Tien P. C., Weber K., Glesby M. J., Villacres M. C., Sharma A., Merenstein D., Golub E. T., Meyer W., Cohen M., Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. Journal of Acquired Immune Deficiency Syndromes 2011 57 3 197 204 2-s2.0-79959763397 10.1097/QAI.0b013e31821ae418
70. Sowers M. R., La Pietra M. T., Menopause: its epidemiology and potential association with chronic diseases. Epidemiologic Reviews 1995 17 2 287 302 2-s2.0-0029551426 (Pubitemid 26096875)
71. Sowers M. R., McConnell D., Yosef M., Jannausch M. L., Harlow S. D., Randolph J. F. Jr., Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period. Annals of the New York Academy of Sciences 2010 1204 95 103 2-s2.0-77956249605 10.1111/j.1749-6632.2010.05523.x
72. Plante B. J., Cooper G. S., Baird D. D., Steiner A. Z., The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years. Menopause 2010 17 3 571 576 2-s2.0-77952254044 10.1097/gme.0b013e3181c7deba
73. Gold E. B., Colvin A., Avis N., Bromberger J., Greendale G. A., Powell L., Sternfeld B., Matthews K., Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. American Journal of Public Health 2006 96 7 1226 1235 2-s2.0-33745656981 10.2105/AJPH.2005.066936 (Pubitemid 43967848)
74. Mattison D. R., Thorgeirsson S. S., Smoking and industrial pollution, and their effects on menopause and ovarian cancer. The Lancet 1978 1 8057 187 188 2-s2.0-0017835087 (Pubitemid 8273527)
75. Paszkowski T., Clarke R. N., Hornstein M. D., Smoking induces oxidative stress inside the Graafian follicle. Human Reproduction 2002 17 4 921 925 2-s2.0-0036117472 (Pubitemid 34411122)
76. Valdez K. E., Petroff B. K., Potential roles of the aryl hydrocarbon receptor in female reproductive senescence. Reproductive Biology 2004 4 3 243 258 2-s2.0-21644442492
77. Gulyas B. J., Mattison D. R., Degeneration of mouse oocytes in response to polycyclic aromatic hydrocarbons. Anatomical Record 1979 193 4 863 882 2-s2.0-0018374941
78. Mattison D. R., Thorgeirsson S. S., Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Research 1979 39 9 3471 3475 2-s2.0-0018650396 (Pubitemid 9255767)
79. Zenzes M. T., Puy L. A., Bielecki R., Immunodetection of cotinine protein in granulosa-lutein cells of women exposed to cigarette smoke. Fertility and Sterility 1997 68 1 76 82 2-s2.0-0030848180 10.1016/S0015-0282(97)81479-3 (Pubitemid 27283720)
80. Zenzes M. T., Krishnan S., Krishnan B., Zhang H., Casper R. F., Cadmium accumulation in follicular fluid of women in in vitro fertilization-embryo transfer is higher in smokers. Fertility and Sterility 1995 64 3 599 603 2-s2.0-0029147460
81. Weiss T., Eckert A., Cotinine levels in follicular fluid and serum of IVF patients: effect on granulose-luteal cell function in vitro. Human Reproduction 1989 4 5 482 485 2-s2.0-0024334009 (Pubitemid 19177256)
82. Bordel R., Laschke M. W., Menger M. D., Vollmar B., Nicotine does not affect vascularization but inhibits growth of freely transplanted ovarian follicles by inducing granulosa cell apoptosis. Human Reproduction 2006 21 3 610 617 2-s2.0-33644867281 10.1093/humrep/dei393 (Pubitemid 43372963)